Last updated: 2026-09-13 07:18:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Becton, Dickinson and Co. (BDX) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NYSE. The stock is currently priced at $177.86, with a market capitalization of $48.44B and a P/E ratio of 51.48. Over the past 52 weeks, its price has ranged from $140.11 to $213.08. This page covers its latest market performance, valuation, price trends and company information.
$48.44B | |
$177.60 | |
$287.32 | |
$34.10 | |
$176.42 | |
1.19M | |
2.10M | |
51.48 | |
$213.08 | |
$140.11 | |
2.42% | |
-- |
Becton, Dickinson and Co. (BDX) last closed at $176.42 as of 2026-09-11 23:31:00, unchanged from the previous close of $176.42.
During the latest regular trading session, BDX traded between $34.10 and $287.32, with a volume of 1.19M shares. The closing price was near the middle and near the middle of its 52-week range.
Over the past seven days, Becton, Dickinson and Co. (BDX) moved from $187.52 to $177.86, representing a decline of 5.15% ($9.66).
The stock traded between $175.16 and $191.76 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 1.53 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 51.7%
BDX is currently trading at $177.86, placing it 51.7% of the way from its 52-week low of $140.11 to its 52-week high of $213.08. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 72000 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Becton, Dickinson and Co. (BDX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.